In a research report released Monday, Brean Capital analyst Difei Yang reiterated a Buy rating on shares of Pernix Therapeutics Holdings Inc (NASDAQ:PTX) with …
Brean Capital’s healthcare analyst Difei Yang came out with a commentary on Zogenix, Inc. (NASDAQ:ZGNX), after the company announced positive top-line results in the Phase …
Brean Capital’s healthcare analyst Difei Yang weighed in today with a favorable report on Zogenix, Inc. (NASDAQ:ZGNX), after a study by scientists at UCSF was recently published …
In a research report released today, Brean Capital analyst Difei Yang maintained a Buy rating on shares of Pernix Therapeutics Holdings Inc (NASDAQ:PTX) with …
Brean Capital’s healthcare analyst Difei Yang weighed in with a few insights on Zogenix, Inc. (NASDAQ:ZGNX), after the company released its second-quarter results, posting revenue of $7.
In a research report published yesterday, Brean Capital analyst Difei Yang reiterated a Buy rating on shares of Pernix Therapeutics Holdings Inc (NASDAQ:PTX) with …
In a research report issued this morning, Brean Capital analyst Difei Yang maintained a Buy rating on shares of Zogenix, Inc. (NASDAQ:ZGNX) and raised the price …
In a research report issued today, Brean Capital analyst Difei Yang reiterated a Buy rating on Horizon Pharma PLC (NASDAQ:HZNP) and raised the price …
In a research report released Wednesday, Brean Capital analyst Difei Yang reiterated a Buy rating on Conatus Pharmaceuticals Inc (NASDAQ:CNAT) with a $13 price …
Brean Capital analyst Difei Yang weighed in today with his prediction Zogenix, Inc. (NASDAQ:ZGNX) ahead of the reverse stock split that will be implemented on …
